Considerations for Long-Term Users If you plan to use BPC-157 beyond a standard 46 week cycle, consider: Taking extended breaks between cycles Using the lowest effective dose Rotating injection sites to avoid local tissue fatigue or inflammation Monitoring subjective markers of progress and potential side effects (energy, GI symptoms, inflammation, blood pressure) Until clinical data becomes available, long-term safety remains uncertain so the guiding principle should be minimal effective use for specific, time-bound recovery goals
Anyone with significant medical conditions, anyone pregnant or breastfeeding, and anyone on multiple medications needs a careful review first not because problems are expected, but because limited human data means we don't assume
There are also negative side effects associated with vitamin B12 injections
The antibodies used include anti-D2R (Santa Cruz Biotechnology, mouse, catalogue# sc-5303) and anti-DAT (Santa Cruz Biotechnology, rat, catalogue# sc-32258)
Using cell culture models and molecular analysis techniques including cDNA microarray, RT/real-time PCR, and Western blotting, researchers demonstrated that BPC-157 treatment upregulates GHR expression in a dose- and time-dependent manner at both the mRNA and protein levels
